Shahla Mirzaeei
1,2*, Kaveh Berenjian
3, Rasol Khazaei
31 Pharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
2 Nano Drug Delivery Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
3 Student Research Committee, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Abstract
Purpose: The poor bioavailability of drugs in the
ocular delivery systems is an important issue and development of delivery
systems with prolonged release profile could be in a major importance. This
study aims to develop an ocular delivery system using electrospun nanofibers to
be a candidate insert for delivery of triamcinolone acetonide.
Methods: For this purpose, three different
chitosan-based formulations were prepared by electrospinning method, and
electrospun nanofibers were compared to a formulation comprising hydrophobic
polymers (Eudragit S100 and Zein). The electrospun nanofibers were
characterized by SEM and FTIR analyses. The release profile and release kinetic
models of all the formulations were also examined.
Results: The SEM photographs of electrospun
nanofibers revealed that among the four designed formulations, formulation
obtained by electrospinning of chitosan and PVP possessed the best quality and
the minimum size (120 ±30 nm) , which resulted the most uniform and bead-free
nanofibers. This formulation also possessed the prolonged release profile of
triamcinolone acetonide and was the only electrospun nanofiber following the
zero-order kinetic profile. Due to the small diameter and uniformity of this
formulation, the prolonged and well controlled release profile, it could be
taken into account as a candidate to overcome the drawbacks of the commonly
used ocular delivery systems and be used as ocular insert.
Conclusion: This study confirmed the ability of electrospun nanofibers to be used as
ocular inserts for delivery of ophthalmic drugs.